Comparing short stitch and traditional suture techniques after liver surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of two surgical closure techniques, short stitch suture and traditional suture, in preventing incisional hernias following liver tumor surgeries. The primary objective is to determine if the small bites abdominal wall closure reduces the risk of hernia development compared to the conventional method. Secondary objectives include assessing short-term outcomes, hernia rates in different patient subgroups, and the impact on quality of life post-surgery. Patients will be randomized into two groups and followed up for a year to monitor outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients undergoing hepatectomy for malignant diagnosis (primary or secondary) from 5/1/2021 through 11/1/2024 will be eligible for inclusion in this study
* Elective surgery
* Age \>= 18
* Planned midline laparotomy incision or inverted-L incision

Exclusion Criteria:

* Pre-existing abdominal hernia
* History of mesh placement at prior laparotomy
* Pregnant women

Where it's running

• M D Anderson Cancer Center
  Houston, Texas, United States Recruiting

Study contacts

• Principal investigator: Timothy E Newhook, MD — M.D. Anderson Cancer Center
• Study coordinator: Timothy E Newhook, MD
• Email: TNewhook@mdanderson.org
• Phone: 713-792-6940

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Local treatment for liver metastases in colorectal cancer patients

  This study tests if combining local treatment for liver tumors with regular cancer therapy can help people with colorectal cancer live longer and feel better.

  Recruiting at 6 sites Anhui Provincial Hospital · Chuzhou, Anhui and 5 other locations · NCT06449937

• Surgical removal followed by targeted radiation therapy for neuroendocrine tumors

  This study is testing if surgery followed by a special radioactive treatment can help people with certain types of cancer that have spread to the liver.

  Recruiting Phase 4 Vanderbilt-Ingram Cancer Center · Nashville, Tennessee · NCT06016855

• Testing pump chemotherapy for liver metastases from colorectal cancer

  This study is testing if adding a special type of chemotherapy delivered directly to the liver can help people with colorectal cancer that has spread to the liver live longer and have fewer problems compared to standard chemotherapy alone.

  Recruiting at 54 sites Phase 3 Eastern Cooperative Oncology Group · Birmingham, Alabama and 61 other locations · NCT05863195

• Using chemotherapy after surgery for high-risk pancreatic neuroendocrine tumors

  This study tests if a combination of two chemotherapy drugs can help prevent cancer from coming back in people who have had surgery for high-risk pancreatic neuroendocrine tumors.

  Recruiting at 381 sites Phase 2 SWOG Cancer Research Network · Anchorage, Alaska and 447 other locations · NCT05040360

• Combining NBTXR3 with radiation and immunotherapy for advanced solid tumors

  This study is testing a new treatment using NBTXR3 along with radiation and immunotherapy to see if it helps people with advanced solid tumors that have spread to the lungs or liver.

  Recruiting Phase 1/2 M.D. Anderson Cancer Center · Houston, Texas · NCT05039632

• New imaging technique to evaluate treatment response in colorectal cancer that has spread to the liver

  This study is testing a new imaging method to see if it can help doctors tell how well chemotherapy is working for people with colorectal cancer that has spread to the liver.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT04796818

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.